medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2007, Número 3

<< Anterior Siguiente >>

Ann Hepatol 2007; 6 (3)


Fatal hepatitis C associated fibrosing cholestatic hepatitis as a complication of cyclophosphamide and corticosteroid treatment of active glomerulonephritis

Saleh F, Ko HH, Davis JE, Apiratpracha W, Powell JJ, Erb SR, Yoshida EM

Idioma: Ingles.
Referencias bibliográficas: 15
Paginas: 186-189
Archivo PDF: 110.74 Kb.


RESUMEN

No tiene resumen


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Davies SE, Portmann BC, O’Grady JG, et al. Hepatic histological findings after transplantation for chronic hepatitis B virus infection, including a unique pattern of fibrosing cholestatic hepatitis. Hepatology 1991; 13: 150–7.

  2. Zylberberg H, Carnot F, Mamzer MF, et al. Hepatitis C virus-related fibrosing cholestatic hepatitis after renal transplantation. Transplantation 1997; 63: 158.

  3. Delladetsima JK, Boletis JN, Makris F, Psichogiou M, Kostakis A, Hatzakis A. Fibrosing cholestatic hepatitis in renal transplant recipients with hepatitis C virus infection. Liver Transpl Surg 1999; 5(4): 294-300.

  4. de Vera ME, Dvorchik I, Tom K, et al. Survival of Liver Transplant Patients Coinfected with HIV and HCV is adversely impacted by recurrent hepatitis C. Am J Transplant 2006.

  5. Agarwal SK, Kalra V, Dinda A, et al. Fibrosing cholestatic hepatitis in renal transplant recipient with CMV infection: a case report. Int Urol Nephrol 2004; 36(3): 433-5.

  6. Furuta K, Takahashi T, Aso K, et al. Fibrosing cholestatic hepatitis in a liver transplant recipient with hepatitis C virus infection: a case report. Transplant Proc 2003; 35(1): 389-91.

  7. Rosenberg PM, Farrell JJ, Abraczinskas DR, et al. Rapidly progressive fibrosing cholestatic hepatitis—hepatitis C virus in HIV coinfection. Am J Gastroenterol 2002; 97(2): 478-83.

  8. Benner KG, Lee RG, Keeffe EB, et al. Fibrosing cytolytic liver failure secondary to recurrent hepatitis B after liver transplantation. Gastroenterology 1992; 103(4): 1307-1312.

  9. Phillips MJ, Cameron R, Flowers MA, et al. Post-transplant recurrent hepatitis B viral liver disease. Viral-burden, steatoviral, and fibroviral hepatitis B. Am J Pathol 1992; 140(6): 1295-1308.

  10. Toth CM, Pascual M, Chung RT, et al. Hepatitis C virus related fibrosing cholestatic hepatitis after renal transplantation. Transplantation 1997; 63: 158-60.

  11. Tillmann HL, Bock CT, Bleck JS, et al. Successful treatment of fibrosing cholestatic hepatitis using adefovir dipivoxil in a patient with cirrhosis and renal insufficiency. Liver Transpl 2003; 9(2): 191-6.

  12. Jamal H, Regenstein F, Farr G, et al. Prolonged survival in fibrosing cholestatic hepatitis with long-term ganciclovir therapy. Am J Gastroenterol 1996; 91: 1027-30.

  13. Faridy KA, Yoshida EM, Davis JE, et al. Alteration of the dismal natural history of fibrosing cholestatic hepatitis secondary to hepatitis B virus with the use of lamivudine. Transplantation 1997; 64: 926-8.

  14. Chan TM, Wu PC, Li FK, et al. Treatment of fibrosing cholestatic hepatitis with lamivudine. Gastroenterology 1998; 115: 177-81.

  15. Schluger LK, Sheiner PA, Thung SN, et al. Severe recurrent cholestatic hepatitis C following orthotopic liver transplantation. Hepatology 1996; 23: 971-76.




2020     |     www.medigraphic.com